159 related articles for article (PubMed ID: 17611632)
1. Identifying prostate carcinoma by MALDI-Imaging.
Schwamborn K; Krieg RC; Reska M; Jakse G; Knuechel R; Wellmann A
Int J Mol Med; 2007 Aug; 20(2):155-9. PubMed ID: 17611632
[TBL] [Abstract][Full Text] [Related]
2. Prostate cancer biomarker discovery using high performance mass spectral serum profiling.
Oh JH; Lotan Y; Gurnani P; Rosenblatt KP; Gao J
Comput Methods Programs Biomed; 2009 Oct; 96(1):33-41. PubMed ID: 19423179
[TBL] [Abstract][Full Text] [Related]
3. Prohibitin identified by proteomic analysis of prostate biopsies distinguishes hyperplasia and cancer.
Ummanni R; Junker H; Zimmermann U; Venz S; Teller S; Giebel J; Scharf C; Woenckhaus C; Dombrowski F; Walther R
Cancer Lett; 2008 Aug; 266(2):171-85. PubMed ID: 18384941
[TBL] [Abstract][Full Text] [Related]
4. Imaging mass spectrometry using chemical inkjet printing reveals differential protein expression in human oral squamous cell carcinoma.
Patel SA; Barnes A; Loftus N; Martin R; Sloan P; Thakker N; Goodacre R
Analyst; 2009 Feb; 134(2):301-7. PubMed ID: 19173053
[TBL] [Abstract][Full Text] [Related]
5. Cross-platform method for identifying candidate network biomarkers for prostate cancer.
Jin G; Zhou X; Cui K; Zhang XS; Chen L; Wong ST
IET Syst Biol; 2009 Nov; 3(6):505-12. PubMed ID: 19947776
[TBL] [Abstract][Full Text] [Related]
6. Influence of blood sampling on protein profiling and pattern analysis using matrix-assisted laser desorption/ionisation mass spectrometry.
Pelzer AE; Feuerstein I; Fuchsberger C; Ongarello S; Bektic J; Schwentner C; Klocker H; Bartsch G; Bonn GK
BJU Int; 2007 Mar; 99(3):658-62. PubMed ID: 17407520
[TBL] [Abstract][Full Text] [Related]
7. Identification of lung cancer patients by serum protein profiling using surface-enhanced laser desorption/ionization time-of-flight mass spectrometry.
Han KQ; Huang G; Gao CF; Wang XL; Ma B; Sun LQ; Wei ZJ
Am J Clin Oncol; 2008 Apr; 31(2):133-9. PubMed ID: 18391596
[TBL] [Abstract][Full Text] [Related]
8. Identification of serum biomarkers for nasopharyngeal carcinoma by proteomic analysis.
Wei YS; Zheng YH; Liang WB; Zhang JZ; Yang ZH; Lv ML; Jia J; Zhang L
Cancer; 2008 Feb; 112(3):544-51. PubMed ID: 18085639
[TBL] [Abstract][Full Text] [Related]
9. Proteomic analysis of conditioned media from the PC3, LNCaP, and 22Rv1 prostate cancer cell lines: discovery and validation of candidate prostate cancer biomarkers.
Sardana G; Jung K; Stephan C; Diamandis EP
J Proteome Res; 2008 Aug; 7(8):3329-38. PubMed ID: 18578523
[TBL] [Abstract][Full Text] [Related]
10. Direct identification of proteins from T47D cells and murine brain tissue by matrix-assisted laser desorption/ionization post-source decay/collision-induced dissociation.
Pevsner PH; Naftolin F; Hillman DE; Miller DC; Fadiel A; Kogus A; Stern A; Samuels HH
Rapid Commun Mass Spectrom; 2007; 21(3):429-36. PubMed ID: 17216666
[TBL] [Abstract][Full Text] [Related]
11. Serum peptidome profiling revealed platelet factor 4 as a potential discriminating Peptide associated with pancreatic cancer.
Fiedler GM; Leichtle AB; Kase J; Baumann S; Ceglarek U; Felix K; Conrad T; Witzigmann H; Weimann A; Schütte C; Hauss J; Büchler M; Thiery J
Clin Cancer Res; 2009 Jun; 15(11):3812-9. PubMed ID: 19470732
[TBL] [Abstract][Full Text] [Related]
12. Proteomic analysis of protein expression in human tonsillar cancer: differentially expressed proteins characterize human tonsillar cancer.
Roblick UJ; Bader FG; Hammarstedt L; Habermann JK; Hellman U; Becker S; Sundmacker A; Gemoll T; Zimmermann K; Auer G; Munck-Wikland E
Acta Oncol; 2008; 47(8):1493-501. PubMed ID: 18759147
[TBL] [Abstract][Full Text] [Related]
13. Reproducibility of serum protein profiling by systematic assessment using solid-phase extraction and matrix-assisted laser desorption/ionization mass spectrometry.
Callesen AK; Christensen Rd; Madsen JS; Vach W; Zapico E; Cold S; Jørgensen PE; Mogensen O; Kruse TA; Jensen ON
Rapid Commun Mass Spectrom; 2008; 22(3):291-300. PubMed ID: 18181248
[TBL] [Abstract][Full Text] [Related]
14. New developments in profiling and imaging of proteins from tissue sections by MALDI mass spectrometry.
Chaurand P; Norris JL; Cornett DS; Mobley JA; Caprioli RM
J Proteome Res; 2006 Nov; 5(11):2889-900. PubMed ID: 17081040
[TBL] [Abstract][Full Text] [Related]
15. Specific MALDI imaging and profiling for biomarker hunting and validation: fragment of the 11S proteasome activator complex, Reg alpha fragment, is a new potential ovary cancer biomarker.
Lemaire R; Menguellet SA; Stauber J; Marchaudon V; Lucot JP; Collinet P; Farine MO; Vinatier D; Day R; Ducoroy P; Salzet M; Fournier I
J Proteome Res; 2007 Nov; 6(11):4127-34. PubMed ID: 17939699
[TBL] [Abstract][Full Text] [Related]
16. Clinical proteomics in breast cancer: a review.
Gast MC; Schellens JH; Beijnen JH
Breast Cancer Res Treat; 2009 Jul; 116(1):17-29. PubMed ID: 19082706
[TBL] [Abstract][Full Text] [Related]
17. Quantitative fluorescence imaging analysis for cancer biomarker discovery: application to beta-catenin in archived prostate specimens.
Huang D; Casale GP; Tian J; Wehbi NK; Abrahams NA; Kaleem Z; Smith LM; Johansson SL; Elkahwaji JE; Hemstreet GP
Cancer Epidemiol Biomarkers Prev; 2007 Jul; 16(7):1371-81. PubMed ID: 17623804
[TBL] [Abstract][Full Text] [Related]
18. A new rule-based algorithm for identifying metabolic markers in prostate cancer using tandem mass spectrometry.
Osl M; Dreiseitl S; Pfeifer B; Weinberger K; Klocker H; Bartsch G; Schäfer G; Tilg B; Graber A; Baumgartner C
Bioinformatics; 2008 Dec; 24(24):2908-14. PubMed ID: 18815183
[TBL] [Abstract][Full Text] [Related]
19. Medical technologies for the diagnosis of prostate cancer.
Fitzsimons NJ; Sun L; Moul JW
Expert Rev Med Devices; 2007 Mar; 4(2):227-39. PubMed ID: 17359227
[TBL] [Abstract][Full Text] [Related]
20. Tutorial: multivariate statistical treatment of imaging data for clinical biomarker discovery.
Deininger SO; Becker M; Suckau D
Methods Mol Biol; 2010; 656():385-403. PubMed ID: 20680603
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
